These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2730243)

  • 1. Positive inotropic effects of milrinone, sulmazole and AR-L100 on isolated normal and infarcted hearts of the rat.
    Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
    Arch Int Pharmacodyn Ther; 1989; 297():7-17. PubMed ID: 2730243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M; Yanagisawa T; Taira N; Blinks JR
    Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of milrinone and sulmazole on left ventricular mechanoenergetics in canine hearts.
    Hata K; Goto Y; Futaki S; Takasago T; Saeki A; Nishioka T; Suga H
    J Card Fail; 1996 Sep; 2(3):203-13. PubMed ID: 8891859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Milrinone decreases the positive inotropic response of heart muscle to izadrin].
    Bardamova IB; Afanas'ev SA
    Eksp Klin Farmakol; 1994; 57(4):29-31. PubMed ID: 7950778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of some new cardiotonic agents on synaptosomal sodium uptake.
    Grima M; Decker N; Schwartz J
    Arzneimittelforschung; 1986 Oct; 36(10):1457-60. PubMed ID: 3814207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro method for measurement of cardiac performance and responses to inotropic drugs after experimentally induced myocardial infarction in the rat.
    Vleeming W; van der Wouw PA; van Rooij HH; Wemer J; Porsius AJ
    J Pharmacol Methods; 1989 Apr; 21(2):95-102. PubMed ID: 2716339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase-inhibiting properties of newer inotropic agents.
    Scholz H; Meyer W
    Circulation; 1986 Mar; 73(3 Pt 2):III99-108. PubMed ID: 2417748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria.
    Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P
    J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
    Hayes JS; Wyss VL; Wilson HC; Robertson DW; Kauffman RF
    J Pharmacol Exp Ther; 1986 Nov; 239(2):375-81. PubMed ID: 3021955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into the inotropic mechanisms of sulmazole.
    Walland A
    Arzneimittelforschung; 1985; 35(1A):369-76. PubMed ID: 4039176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of milrinone on the electrocardiogram and the cardiac hemodynamics of rats with pressure overload-induced congestive heart failure.
    Desjardins S; Cauchy MJ
    Arch Int Pharmacodyn Ther; 1989; 301():182-99. PubMed ID: 2624514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
    Heber D; Heers C; Ravens U
    Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulmazole effects on mechanical performance of hypoxic and reoxygenated isolated mammalian myocardium.
    Bonoron-Adèle S; Grellet J; Bricaud H; Tariosse L; Besse P
    Arzneimittelforschung; 1986 Nov; 36(11):1572-7. PubMed ID: 3814219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of 4-epiadriamycin cardiotoxicity by milrinone, a new cardiotonic agent.
    Bossa R; Aresca P; Galatulas I; Ninci M
    Anticancer Res; 1989; 9(3):605-8. PubMed ID: 2764506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
    Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
    J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of milrinone on ethanol and halothane induced cardiodepression.
    Neira S; Penna M
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):193-211. PubMed ID: 2847492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
    Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
    Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
    Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
    Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.